Aired: 12:00pm ET | 22 October, 2019
Did you know that data integrity issues were cited in 65% of all FDA warning letters in 2017? The main reason was due to having incomplete data. In the Pharma and Biotech Industries this can be prevented by ensuring the trustworthiness and reliability of electronic records, a process that is also known as Compliance with Data Integrity. The highest risks, when not working in a compliant manner, lie in import bans, product recalls or even the closing of production plants.
Attendees will Learn the Following During this Presentation: